Lidia Stork

Robert Koch Str, 40
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Brain Immune Cell Composition in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy After Natalizumab: An Immunohistochemical Cohort Study.

Brain Immune Cell Composition in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy After Natalizumab: An Immunohistochemical Cohort Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 11, 2026

Histopathologically confirmed radiation necrosis: Risk factors and clinical outcomes in patients with primary brain tumors.

Histopathologically confirmed radiation necrosis: Risk factors and clinical outcomes in patients with primary brain tumors.

Journal: Neuro-oncology practice

Published: August 15, 2025

Impaired remyelination in late-onset multiple sclerosis.

Impaired remyelination in late-onset multiple sclerosis.

Journal: Acta neuropathologica

Published: January 17, 2025

Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroids.

Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroids.

Journal: Free neuropathology

Published: August 01, 2023

Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological-serological correlative study.

Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological-serological correlative study.

Journal: Journal of neurology

Published: September 19, 2022

An unusual lymphoid lesion mimicking meningioma.

An unusual lymphoid lesion mimicking meningioma.

Journal: Brain pathology (Zurich, Switzerland)

Published: February 06, 2021

CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study.

CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study.

Journal: Brain pathology (Zurich, Switzerland)

Published: December 01, 2020

Antibody signatures in patients with histopathologically defined multiple sclerosis patterns.

Antibody signatures in patients with histopathologically defined multiple sclerosis patterns.

Journal: Acta neuropathologica

Published: October 24, 2019

Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis.

Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 19, 2019

Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.

Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.

Journal: JAMA neurology

Published: February 07, 2018

Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy.

Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy.

Journal: Neurology

Published: November 28, 2017

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 14, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026